News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Freedberg Jared
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/03/2023 |
4
| Freedberg Jared (General Counsel) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 771 shares
@ $10.5, valued at
$8.1k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2023 |
4
| Freedberg Jared (General Counsel) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 12,200 shares
@ $0
Granted 20,000 options to buy
@ $18.4, valued at
$368k
|
|
| 01/03/2023 |
4
| Freedberg Jared (General Counsel) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 718 shares
@ $12.37, valued at
$8.9k
|
|
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Freedberg Jared (General Counsel) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 771 shares
@ $15.71, valued at
$12.1k
|
|
| 01/31/2022 |
4
| Freedberg Jared (General Counsel) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.|
Txns:
| Granted 10,300 shares
@ $0
Granted 17,600 options to buy
@ $14.44, valued at
$254.1k
|
|
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/23/2020 |
4
| Freedberg Jared (Gen. Counsel & Corp. Secretary) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Disposed/sold 280,105 options to buy
@ $0 |
|
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2019 |
4
| Freedberg Jared (GENERAL COUNSEL) has filed a Form 4 on IMMUNOMEDICS INC|
Txns:
| Granted 27,560 options to buy
@ $17.94, valued at
$494.4k
Granted 13,780 options to buy
@ $17.94, valued at
$247.2k
|
|
| 09/26/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|